Israeli Biomed NeuroDerm sells for $1.1 Billion in Cash to Japanese Mitsubishi Tanabe
The price for NeuroDerm, the largest ever acquisition of an Israeli pharmaceuticals company, reflects a 17% premium on the share price on July 21
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
